Growing community of inventors

Boston, MA, United States of America

Donald Raymond Shaffer

Average Co-Inventor Count = 5.69

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Donald Raymond ShafferGlenn Dranoff (3 patents)Donald Raymond ShafferNir Hacohen (3 patents)Donald Raymond ShafferHarvey I Cantor (3 patents)Donald Raymond ShafferKai W Wucherpfennig (3 patents)Donald Raymond ShafferDiana Alvarez Arias (3 patents)Donald Raymond ShafferPenghui Zhou (3 patents)Donald Raymond ShafferHeather B Cohen (2 patents)Donald Raymond ShafferLauren Pepper Mackenzie (2 patents)Donald Raymond ShafferJeffrey Yan-Fei Smith (2 patents)Donald Raymond ShafferYasmin Ramsay (1 patent)Donald Raymond ShafferDonald Raymond Shaffer (5 patents)Glenn DranoffGlenn Dranoff (30 patents)Nir HacohenNir Hacohen (27 patents)Harvey I CantorHarvey I Cantor (20 patents)Kai W WucherpfennigKai W Wucherpfennig (20 patents)Diana Alvarez AriasDiana Alvarez Arias (3 patents)Penghui ZhouPenghui Zhou (3 patents)Heather B CohenHeather B Cohen (2 patents)Lauren Pepper MackenzieLauren Pepper Mackenzie (2 patents)Jeffrey Yan-Fei SmithJeffrey Yan-Fei Smith (2 patents)Yasmin RamsayYasmin Ramsay (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The General Hospital Corporation (3 from 2,893 patents)

2. Dana-farber-cancer Institute Inc. (3 from 1,210 patents)

3. Jounce Therapeutics, Inc. (2 from 10 patents)

4. The General Hospital Corporation D/b/a Massachusetts General Hospital (1 patent)


5 patents:

1. 11597934 - Methods and compositions for reducing immunosuppression by tumor cells

2. 11359019 - Antibodies to LILRB2

3. 10876120 - Methods and compositions for reducing immunosupression by tumor cells

4. 10723798 - Antibodies to LILRB2

5. 9944931 - Methods and compositions for reducing immunosupression by tumor cells

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…